Liu, S., Yu, M., Mou, E., Wang, M., Liu, S., Xia, L., Li, H., Tang, H., Feng, Y., Yu, X., Mi, K., Wang, H. (2025). The optimal neoadjuvant treatment strategy for HR+/HER2 + breast cancer: a network meta-analysis. Scientific Reports. https://doi.org/10.1038/s41598-024-84039-2